- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit
- Join Join
Noelle Crombie, The Oregonian
The U.S. House of Representatives early Friday voted for an amendment that blocks the U.S. Department of Justice from meddling in states' medical marijuana laws.
The Associated Press reports that the vote, 219-189, was "somewhat surprising" for the GOP-controlled House. The wire service reports that the vote came as the House considered the budget for the Justice Department. It now heads to the Democratic Senate.
The amendment was sponsored by U.S. Rep. Dana Rohrabacher, R-Calif., and 11 others, including U.S. Rep. Earl Blumenauer, D-Ore., an outspoken proponent of reforming federal marijuana policy.
In a piece published on the The National Review website this week, Rohrabacher writes that the federal government should acknowledge the growing public support for medical marijuana.
More than half the states allow people with serious illnesses to use marijuana and its derivatives. The vast majority of Americans — about 85 percent, according to recent polls — support this policy. What's driving this surge is the realization by patients, researchers, and physicians that such treatment may offer enormous relief for numerous patients. I would lay this positive research against the more alarmist findings any day. It is cruel for political Washington to ignore humane sentiment for most Americans.
Opponents of Rohrabacher's amendment say states aren't doing enough to regulate medical marijuana.
Rep. Andy Harris, R-Md., cited a recent Drug Enforcement Administration study that said that many in the medical marijuana movement are using it as "a means to an end," meaning legalization for recreational use.
But medical marijuana advocates hailed the vote as victory.
Steph Sherer, executive director of Americans for Safe Access, a national group that advocates for medical marijuana patients, called the vote a "game changer."
"No longer will we have to look over our shoulder and worry when the next raid or indictment will prevent us from safely and legally accessing our medicine," Sherer said in an email to media outlets, including The Oregonian.
Sherer's organization has highlighted what it considers the aggressive prosecution of a group of medical marijuana growers in Washington. The Kettle Falls, Wash., residents say their activities, though illegal under federal law, were legal under Washington law.